Hoje é dia de “post preguiçoso”, documento disponível sobre inovação disruptiva em saúde, versão final (aqui), no seguimento do post sobre “disruptive innovation” de há uns meses atrás. Para conhecimento e discussão.
Disruptive Innovation: Final EXPH Opinion adopted
Today, the Commission’s independent Expert Panel which gives non-binding advice on matters related to “effective ways of investing in health”, adopted its opinion on the implications of Disruptive Innovation for health and health care in Europe. This final opinion reflects the comments received during the public consultation period, during which contributions were received from 25 parties.
Innovation can be categorised as non-disruptive or disruptive. Non-disruptive innovations aim to make improvements to existing systems without overly disrupting the status quo. Disruptive innovations, as the name suggests, are more radical. They result in organisational changes, new networks and new players, and displace older organisational structures, workforce, processes, products, services and technologies.
The Opinion aims to identify drivers and barriers for the implementation of disruptive innovation, assesses its relevance in the EU, and identify strategic areas of focus.
It finds that disruptive innovation can be an important mechanism for improving health and health care in Europe. Disruptive innovations provide new and different perspectives that, in the long run, tend to reduce costs and complexity in favour of improved access and the empowerment of the citizen/patient. Policy makers should thus, see disruptive innovations as possible new ways of developing sustainable European health systems.
Barriers to disruptive innovation include lack of engagement of patients/people, lack of coordination, resistance of the health workforce and organisational/institutional structures, inadequate networks and processes, economic and legal factors and lack of political support.
The implementation of any (disruptive) innovation should carefully address the issues of relevance, equity (including access), quality, cost-effectiveness, person- and people centeredness, and sustainability. Health policy should be designed to encourage enablers for developing and implementing disruptive innovations and reduce the potential barriers.
While disruptive innovation can be an important concept for policy analysis, it does not mean that other types of innovation are less desirable. Incremental innovation can be very important, as well as more radical innovations that may not be classified as disruptive.
Conteúdo do trabalho:
THE CONCEPT OF DISRUPTIVE INNOVATION;
CHRISTENSEN CONCEPT OF DISRUPTIVE INNOVATION;
DISRUPTIVE INNOVATION IN HEALTH CARE (The applicability of disruptive innovation to health care; EXPH concept of disruptive; Elements that characterise disruptive innovation);
TAXONOMY OF DISRUPTIVE INNOVATION; DIFFERENT OPTIONS TO CLASSIFY DISRUPTIVE INNOVATIONS; THE FIELD OF APPLICATION; EXAMPLES ILLUSTRATING THE TAXONOMY; STRATEGIC AREAS FOR DISRUPTIVE INNOVATION;
DISRUPTIVE INNOVATION AND TRANSLATIONAL RESEARCH; DISRUPTIVE INNOVATION AND TECHNOLOGY IN MEDICINE; DISRUPTIVE INNOVATION AND PRECISION MEDICINE;
DISRUPTIVE INNOVATION AND HEALTH AND CARE PROFESSIONAL;
DISRUPTIVE INNOVATION AND HEALTH PROMOTION;
IMPLEMENTING DISRUPTIVE INNOVATION; FACTORS THAT TRIGGER DISRUPTIVE INNOVATIONS IN HEALTH (BARRIERS TO DISRUPTIVE INNOVATION IMPLEMENTATION; ADOPTION AND DIFFUSION OF DISRUPTIVE INNOVATION; POLICY ISSUES);
CASE STUDIES: NEW AND MORE EFFECTIVE TREATMENT FOR HCV; COMMUNITY-BASED MENTAL HEALTH; POPULATION BASED ACCOUNTABLE ORGANISATIONS; ANTI-ULCER DRUGS; DIABETIC PATIENT SELF-MANAGEMENT; MINIMAL INVASIVE SURGERY; PATIENT-CENTRED CARE; THE SWEDISH REHABILITATION GUARANTEE;
CONCLUSIONS AND POLICY RECOMMENDATIONS